These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 33512780)
1. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size. Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780 [TBL] [Abstract][Full Text] [Related]
2. Sulfated Hyaluronan Modulates the Functional Properties and Matrix Effectors Expression of Breast Cancer Cells with Different Estrogen Receptor Status. Koutsakis C; Tavianatou AG; Kokoretsis D; Baroutas G; Karamanos NK Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944559 [TBL] [Abstract][Full Text] [Related]
3. Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells. Tavianatou AG; Piperigkou Z; Barbera C; Beninatto R; Masola V; Caon I; Onisto M; Franchi M; Galesso D; Karamanos NK Matrix Biol Plus; 2019 Aug; 3():100008. PubMed ID: 33543007 [TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer. Piperigkou Z; Franchi M; Götte M; Karamanos NK Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer. Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222 [TBL] [Abstract][Full Text] [Related]
7. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition. Karamanou K; Franchi M; Piperigkou Z; Perreau C; Maquart FX; Vynios DH; Brézillon S Sci Rep; 2017 Mar; 7():45138. PubMed ID: 28332606 [TBL] [Abstract][Full Text] [Related]
8. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid. Dedes PG; Gialeli Ch; Tsonis AI; Kanakis I; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK Biochim Biophys Acta; 2012 Dec; 1820(12):1926-39. PubMed ID: 22884656 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signaling. Karamanou K; Franchi M; Onisto M; Passi A; Vynios DH; Brézillon S FEBS J; 2020 Nov; 287(22):4862-4880. PubMed ID: 32160387 [TBL] [Abstract][Full Text] [Related]
10. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration. Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740 [TBL] [Abstract][Full Text] [Related]
11. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells. Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules. Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695 [TBL] [Abstract][Full Text] [Related]
13. ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer. Kyriakopoulou K; Riti E; Piperigkou Z; Koutroumanou Sarri K; Bassiony H; Franchi M; Karamanos NK Cells; 2020 Oct; 9(10):. PubMed ID: 33050027 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290 [TBL] [Abstract][Full Text] [Related]
15. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism. Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387 [TBL] [Abstract][Full Text] [Related]
16. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Ween MP; Hummitzsch K; Rodgers RJ; Oehler MK; Ricciardelli C Clin Exp Metastasis; 2011 Feb; 28(2):113-25. PubMed ID: 21153687 [TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells. Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer. Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395 [TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-mediated targeting of the extracellular matrix network in cancer. Piperigkou Z; Karamanos NK Semin Cancer Biol; 2020 May; 62():116-124. PubMed ID: 31310807 [TBL] [Abstract][Full Text] [Related]
20. Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro. Herrera-Gayol A; Jothy S Int J Exp Pathol; 2001 Jun; 82(3):193-200. PubMed ID: 11488992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]